PROXYPHARMA LLB
0898.752.807 · rovalta.com · 21/09/2026
PROXYPHARMA LLB
Overview
What does PROXYPHARMA LLB do?
PROXYPHARMA LLB is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in La Bruyère. It employs on average 2,1 ETP workers (FTE).
5081 La Bruyère · WallonieSee on map
Joint committees (1)
- 313
Trend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||
| Gross margin | 216,6 k € | -1.3% | 219,5 k € | +13.6% | 193,2 k € | -10.4% | 215,7 k € | +27.4% | 169,3 k € | +17.4% | 144,2 k € | -11.0% | 162,2 k € | -27.4% | 223,4 k € | +122% | 100,8 k € | +10976% | 910,4 € | -0.1% | 911,4 € | -0.5% | 915,5 € | -6.7% | 980,9 € | +150% | -2,0 k € | -2577% | -73,0 € |
| EBITDA | 53,2 k € | -8.7% | 58,2 k € | -42.2% | 100,8 k € | -9.3% | 111,1 k € | +26.3% | 87,9 k € | +127% | 38,7 k € | -37.0% | 61,4 k € | -38.1% | 99,2 k € | +158% | 38,5 k € | +6743% | 562,9 € | -0.2% | 563,9 € | -0.7% | 568,0 € | -10.3% | 633,4 € | +128% | -2,3 k € | -200% | -768,0 € |
| Operating result | 43,2 k € | -1.8% | 44,0 k € | -49.8% | 87,6 k € | -12.0% | 99,5 k € | +53.3% | 64,9 k € | +5228% | 1,2 k € | -92.7% | 16,6 k € | -67.7% | 51,3 k € | +297% | 12,9 k € | +2199% | 562,9 € | +22.3% | 460,4 € | +27.5% | 361,0 € | -15.4% | 426,4 € | +117% | -2,5 k € | -133% | -1,1 k € |
| Net result | 35,3 k € | +1.6% | 34,7 k € | -51.4% | 71,4 k € | -9.8% | 79,2 k € | +90.2% | 41,6 k € | +700% | -6,9 k € | -196% | 7,2 k € | -81.0% | 38,0 k € | +2183% | -1,8 k € | -431% | 550,9 € | +26.7% | 434,7 € | +12.0% | 388,1 € | -27.9% | 538,3 € | +123% | -2,4 k € | -132% | -1,0 k € |
| Balance sheet | |||||||||||||||||||||||||||||
| Equity | 532,8 k € | -4.4% | 557,5 k € | -2.7% | 572,7 k € | +3.9% | 551,3 k € | +5.6% | 522,1 k € | +5.5% | 495,1 k € | -1.4% | 502,0 k € | +1.5% | 494,8 k € | +8.3% | 456,8 k € | +4087% | 10,9 k € | +5.3% | 10,4 k € | +4.4% | 9,9 k € | +4.1% | 9,5 k € | +6.0% | 9,0 k € | -20.9% | 11,4 k € |
| Total assets | 707,6 k € | -8.9% | 776,8 k € | +2.0% | 761,6 k € | +1.2% | 752,8 k € | +15.1% | 654,3 k € | -0.3% | 656,2 k € | -6.1% | 699,0 k € | +2.9% | 679,2 k € | +2.3% | 664,2 k € | +5975% | 10,9 k € | +5.3% | 10,4 k € | +4.4% | 9,9 k € | +4.3% | 9,5 k € | +6.0% | 9,0 k € | -20.9% | 11,4 k € |
| Cash | 86,3 k € | -45.7% | 159,0 k € | +298% | 40,0 k € | -71.5% | 140,3 k € | +10.5% | 126,9 k € | +41.0% | 90,0 k € | -34.4% | 137,1 k € | -23.6% | 179,5 k € | +41.8% | 126,5 k € | +1060% | 10,9 k € | +5.3% | 10,4 k € | +5.5% | 9,8 k € | +6.7% | 9,2 k € | +8.8% | 8,5 k € | -20.6% | 10,7 k € |
| Debts | 174,8 k € | -20.3% | 219,4 k € | +16.2% | 188,9 k € | -6.3% | 201,5 k € | +52.4% | 132,2 k € | -17.9% | 160,9 k € | -18.3% | 197,0 k € | +6.8% | 184,4 k € | -11.1% | 207,4 k € | +836617% | 24,8 € | 0.0% | 24,8 € | 0.0% | 24,8 € | – | – | – | |||
| Other | |||||||||||||||||||||||||||||
| Workforce | 2,1 ETP | 0.0% | 2,1 ETP | -4.5% | 2,2 ETP | 0.0% | 2,2 ETP | +22.2% | 1,8 ETP | -18.2% | 2,2 ETP | +4.8% | 2,1 ETP | -4.5% | 2,2 ETP | 0.0% | 2,2 ETP | – | – | – | – | – | – | ||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 3 active · 6 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ISLOIS● Active | 0460.395.355 |
UNITE TVA DU GROUPE LOISE● Active | 0644.672.094 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/07/2026 | 16/07/2025 | 14/06/2024 | 09/06/2023 | 20/06/2022 | 17/06/2021 |
| General meeting | 30/06/2026 | 20/06/2025 | 14/06/2024 | 09/06/2023 | 10/06/2022 | 11/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
17 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 24/07/2026 | French | |
| Abridged model | 31/12/2024 | 20/06/2025 | 16/07/2025 | French | |
| Abridged model | 31/12/2023 | 14/06/2024 | 14/06/2024 | French | |
| Abridged model | 31/12/2022 | 09/06/2023 | 09/06/2023 | French | |
| Abridged model | 31/12/2021 | 10/06/2022 | 20/06/2022 | French | |
| Abridged model | 31/12/2020 | 11/06/2021 | 17/06/2021 | French | |
| Abridged model | 31/12/2019 | 12/06/2020 | 15/06/2020 | French | |
| Abridged model | 31/12/2018 | 14/06/2019 | 26/06/2019 | French | |
| Abridged model | 31/12/2017 | 08/06/2018 | 18/06/2018 | French | |
| Abridged model | 31/12/2016 | 14/06/2017 | 10/07/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 14/07/2016 | French | |
| Abridged model | 31/12/2014 | 12/06/2015 | 09/07/2015 | French | |
| Abridged model | 31/12/2013 | 13/06/2014 | 10/07/2014 | French | |
| Abridged model | 31/12/2012 | 14/06/2013 | 18/06/2013 | French | |
| Abridged model | 31/12/2011 | 08/06/2012 | 06/07/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 25/07/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 29/07/2010 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 3 active · 6 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates15/02/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Restructuring29/12/2015DENOMINATION - OBJET - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring07/10/2015RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Other26/06/2008RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202535,3 k €↑
- 2024Annual accounts 202434,7 k €↓
- 2023Annual accounts 202371,4 k €↓
- 2022Annual accounts 202279,2 k €↑
- 2021Annual accounts 202141,6 k €↑
- 2018Annual accounts 2018-6,9 k €↓
- 2017Annual accounts 20177,2 k €↓
- 2016Annual accounts 201638,0 k €↑
- 2015Annual accounts 2015-1,8 k €↓
- 2015Name changeProxypharma LLB
- 2014Annual accounts 2014550,9 €↑
- 2013Annual accounts 2013434,7 €↑
- 2012Annual accounts 2012388,1 €↓
- 2011Annual accounts 2011538,3 €↑
- 2010Annual accounts 2010-2,4 k €↓
- 2009Annual accounts 2009-1,0 k €
- 2009Name changeLOISAC
- 24/06/2008IncorporationPrivate limited company